TRANSLATE

The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Editorial theme | Differential diagnosis and the importance of early treatment

Featured:

Ulrich MrowietzUlrich MrowietzPaolo GisondiPaolo Gisondi

Jun 14, 2023

Learning objective: After reading this article, learners will be able to cite a new development in psoriasis.


During the Psoriasis and Psoriatic Arthritis Hub Steering Committee meeting, key opinion leaders met to discuss differential diagnosis and the importance of early treatment in psoriasis and psoriatic arthritis as part of our editorial theme on delayed diagnosis. This recorded discussion was chaired by Peter van de Kerkhof, and featured Ulrich Mrowietz and Paolo Gisondi.

Differential diagnosis and the importance of early treatment in psoriasis and psoriatic arthritis

In this discussion, van de Kerkhof opens by highlighting some of the factors that feed into early treatment of psoriasis and psoriatic disease, and then the impact of a late diagnosis, focusing on the negative impacts on quality of life (QoL). He goes on to discuss the importance of early diagnosis to mitigate this decline in QoL and for long-term sustainable disease control.

Mrowietz closes the discussion by sharing the spectrum of psoriatic disease (Figure 1), discussing how early treatment can be used to target multiple aspects of psoriatic disease, including its comorbidities.

Figure 1. Psoriatic disease spectrum* 

*Adapted from Mrowietz, et al.1

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content